Pathway to biosimilars is critical to industry, MBC tells NECN

July 30, 2009
MBC President & CEO Robert K. Coughlin and Timothy Hunt, Vice President of Public Affairs at Biogen Idec spoke with New England Cable News about the importance of a safe and effective pathway to biosimilars.

Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon Sign up for our Upcoming Events email!
For Email Marketing you can trust

MassBio